Retrieved 13 June Many physicians operate by the World Professional Association of Transgender Health WPATH Standards of Care SoC model and require psychotherapy and a letter of recommendation from a psychotherapist in order for a transgender person to obtain hormone therapy. Follicle-stimulating hormone Human chorionic gonadotropin Luteinizing hormone Menotropin Urofollitropin. Many transgender individuals seek out hormone replacement therapy HRT during their transition. Fat on the hips, thighs, and buttocks has a higher concentration of omega-3 fatty acids and is meant to be used for lactation. Raising the dosage of estrogen or adding a progestogen raises the libido of some transgender women.
The nonsteroidal antiandrogens that have been used in transgender women include the first-generation medications flutamide Eulexinnilutamide Anandron, Nilandronand bicalutamide Casodex.
Transgender hormone therapy (male-to-female)
Management of Gender Dysphoria: Many apocrine glands — a type of sweat gland — become inactive, and body odor decreases. Transgender patients opting for breast reduction are rare. Hair Growth and Disorders. A number of male gender characteristics gradually disappear into the background. To this is added estrogens, which are provided both in tablet form and in patches. PR agonists Progesterone derivatives:
However, many transgender women report there is often a "stall" in breast growth during transition, or significant breast asymmetry. However, this decline in fertility due to estrogen therapy is controversial due to limited studies. Fat on the hips, thighs, and buttocks has a higher concentration of omega-3 fatty acids and is meant to be used for lactation. Golomb 28 June The Endocrine Society stated in that individuals should either have a documented three months of RLE or undergo psychotherapy for a period of time specified by their mental health provider, usually a minimum of three months. De Groot 18 May